The information highlighted (if any) are the most recent updates for this brand.
Pergoveris is indicated for the stimulation of follicular development in women with severe luteinizing hormone (LH) and follicle stimulating hormone (FSH) deficiency. In clinical trials, these patients were defined by an endogenous serum LH level <1.2 IU/L.